Here's where most guides fail researchers. CJC-1295 exists in two distinct forms, and choosing the wrong one for your goals can mean the difference between optimal results and wasted effort.
This comparison does not assign a generated winner or score.
Peptides like Ipamorelin, GHRP-2, and GHRP-6 work through a different mechanism, stimulating GH release via growth hormone secretagogue receptors rather than GHRH receptors. These…
View details →CJC-1295 isn't the only option for researchers interested in GHRH modulation. Understanding how it compares to alternatives helps in selecting the right peptide for specific goals.
View details →Sermorelin is a 29-amino acid peptide corresponding to the first 29 amino acids of natural GHRH. Unlike CJC-1295, it lacks the modifications that provide DPP-IV resistance. The re…
View details →Tesamorelin (Egrifta) is an FDA-approved GHRH analog used to reduce abdominal fat in HIV patients with lipodystrophy. It has a modified amino acid sequence that improves stability…
View details →Synthetic human growth hormone (somatropin) directly introduces GH into the body, bypassing the pituitary entirely. HGH produces predictable, dose-dependent GH elevation, but it a…
View details →The terminology around CJC-1295 peptide is a common source of confusion in research settings. CJC-1295 with DAC refers to the original formulation developed by ConjuChem Biotechno…
View details →